House Bill 95

Actions | Amendments
Last Action 03/05/21: passed 35-0 with Committee Substitute and floor amendments (3) and (2-title)
Title AN ACT relating to prescription insulin.
Bill Documents Current
Introduced
Fiscal Impact Statements Health Mandate
Additional Fiscal Impact Statements Exist
Bill Request Number 831
Sponsors D. Bentley, P. Minter, K. Banta, J. Blanton, T. Bojanowski, J. Branscum, J. Bray, R. Bridges, G. Brown Jr., T. Burch, J. Calloway, M. Cantrell, J. Decker, J. Donohue, M. Dossett, R. Dotson, J. DuPlessis, D. Elliott, J. Fischer, D. Fister, P. Flannery, K. Flood, D. Frazier, C. Fugate, A. Gentry, J. Gooch Jr., D. Graham, D. Hale, M. Hart, A. Hatton, S. Heavrin, T. Huff, J. Jenkins, DJ Johnson, K. King, N. Kirk-McCormick, N. Kulkarni, W. Lawrence, S. Lewis, M. Marzian, C. Massey, B. McCool, M. Meredith, C. Miller, R. Palumbo, P. Pratt, M. Prunty, J. Raymond, B. Reed, S. Riley, R. Roberts, S. Rudy, S. Santoro, A. Scott, S. Sharp, S. Sheldon, C. Stevenson, P. Stevenson, A. Tackett Laferty, N. Tate, W. Thomas, J. Tipton, K. Upchurch, R. Webber, B. Wesley, S. Westrom, B. Wheatley, L. Willner
Summary of Original Version Amend KRS 304-17A.148 to cap the cost-sharing requirements for prescription insulin at $30 per 30 day supply; amend KRS 18A.225 to require the Kentucky Employee Health Plan to comply; EFFECTIVE January 1, 2022.
Index Headings of Original Version Health Benefit Mandate - Prescription insulin drugs, cost sharing, cap
Diseases - Diabetes, prescription insulin drugs, cost sharing, cap
Drugs and Medicines - Prescription insulin drugs, cost sharing, cap
Effective Dates, Delayed - Prescription insulin drugs, cost sharing, January 1, 2022
Insurance, Health - Prescription insulin drugs, cost sharing, cap
Jump to Proposed Amendments House Committee Substitute 1 with Fiscal Impact Statements
Senate Committee Substitute 1 with Fiscal Impact Statements
Senate Floor Amendment 1
Senate Floor Amendment 2
Senate Floor Amendment 3
Votes Vote History

Actions

Top | Amendments
11/19/20
  • Prefiled by the sponsor(s).
01/05/21
  • introduced in House
  • to Committee on Committees (H)
02/02/21
  • to Health & Family Services (H)
02/10/21
  • posted in committee
02/11/21
  • reported favorably, 1st reading, to Calendar with Committee Substitute
02/22/21
  • 2nd reading, to Rules
  • posted for passage in the Regular Orders of the Day for Tuesday, February 23, 2021
02/23/21
  • 3rd reading, passed 95-0 with Committee Substitute
02/24/21
  • received in Senate
  • to Committee on Committees (S)
02/26/21
  • to Banking & Insurance (S)
03/02/21
  • reported favorably, 1st reading, to Consent Calendar with Committee Substitute (1)
  • floor amendment (1) filed to Committee Substitute, floor amendment (2) filed to bill
03/03/21
  • 2nd reading, to Rules
  • posted for passage in the Regular Orders of the Day for Friday, March 5, 2021
03/04/21
  • floor amendment (3) filed to Committee Substitute
03/05/21
  • 3rd reading
  • floor amendment (1) withdrawn
  • passed 35-0 with Committee Substitute and floor amendments (3) and (2-title)

Proposed Amendments

Top | Actions
Amendment House Committee Substitute 1
Fiscal Impact Statement Health Mandate to House Committee Substitute 1
Summary Retain original provisions; delete provision prohibiting an insurer with a cost-sharing requirment of less than $30 for a 30 day supply of prescription inuslin on the effective date of this Act from increasing that cost-sharing requirement; define "cost sharing."
Index Headings Diseases - Prescription insulin drugs, cost sharing, cap
Drugs and Medicines - Prescription insulin drugs, cost sharing, cap
Effective Dates, Delayed - Prescription insulin drugs, cost sharing, January 1, 2022
Health Benefit Mandate - Prescription insulin drugs, cost sharing, cap
Insurance, Health - Prescription insulin drugs, cost sharing, cap

Amendment Senate Committee Substitute 1
Fiscal Impact Statement Health Mandate to Senate Committee Substitute 1
Summary Retain original provisions; increase cap on cost-sharing requirements for prescription insulin to $35 for a 30 day supply; EFFECTIVE January 1, 2022.
Index Headings Diseases - Diabetes, prescription insulin drugs, cost sharing, cap
Drugs and Medicines - Prescription insulin drugs, cost sharing, cap
Effective Dates, Delayed - Prescription insulin drugs, cost sharing, January 1, 2022
Insurance, Health - Prescription insulin drugs, cost sharing, cap
Health Benefit Mandate - Prescription insulin drugs, cost sharing, cap

Amendment Senate Floor Amendment 1
Sponsor J. Carpenter
Summary Delete delayed effective date and replace with emergency clause. EMERGENCY.
Index Headings Effective Dates, Emergency - Prescription insulin drugs, cost sharing, cap

Amendment Senate Floor Amendment 2
Sponsor J. Carpenter
Summary Make title amendment.
Index Headings Title Amendments - HB 95/GA

Amendment Senate Floor Amendment 3
Sponsor J. Carpenter
Summary Provide that section on diabetes coverage is subject to federal law and regulations; delete delayed effective date and replace with emergency clause. EMERGENCY.
Index Headings Federal Laws and Regulations - Health benefit plans, diabetes, coverage
Effective Dates, Emergency - Prescription insulin drugs, cost sharing, cap

Last updated: 3/5/2021 7:16 PM (EST)
To receive notice when the record is updated follow @LRCTweetBot.